Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    FDA reiterates hydroxychloroquine limitations for COVID-19

    April 24, 2020

    An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial.

  • 1
    News

    COVID-19: What are the major cardiovascular issues?

    April 24, 2020

    COVID myocarditis can mimic acute MI or stress cardiomyopathy and will present diagnostic and therapeutic challenges.

  • News

    Angiotensin drugs and COVID-19: More reassuring data

    April 24, 2020

    Data from one Wuhan hospital show no difference in COVID-19 severity or mortality in patients with hypertension taking ACE inhibitors or ARBs. Other reassuring studies are also emerging.

  • 1
    News

    AUGUSTUS: After ACS or PCI, aspirin gives AFib patients scant benefit

    April 24, 2020

    Adding aspirin to an anticoagulant and P2Y12 inhibitor showed no net benefit, even acutely, suggesting need to target aspirin to highly selected patients.

  • 1
    News

    Hydroxychloroquine ineffective for COVID-19, VA study suggests

    April 23, 2020

    The retrospective study, which included data from 368 men hospitalized with confirmed COVID-19 and treated in VA medical centers, showed an association between HCQ and higher mortality.

  • News

    Signature STEMI sign may be less diagnostic in the COVID-19 age

    April 22, 2020

    ST-segment elevation, often a ticket to the cath lab, may not indicate STEMI as reliably as before hospitals started to fill with COVID-19 patients, who may have other ST-segment–elevating conditions.

  • 1
    News

    ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients

    April 22, 2020

    A study drawing from 1,128 hypertensive, Chinese patients with COVID-19 suggested that those on an ACEI or ARB had better 28-day survival.

  • News

    Mislabeled clopidogrel lot recalled, may contain simvastatin

    April 21, 2020

    International Laboratories has recalled one lot of clopidogrel tablets packaged in bottles of 30 tablets because it may contain simvastatin instead of clopidogrel.

  • News

    ASE issues echocardiography guidance amid COVID-19 pandemic

    April 21, 2020

    The ASE urges careful consideration of whom, where, and how to image to reduce the risks of SARS-CoV-2 transmission among echocardiography providers.

  • 1
    News

    PCSK9 inhibitors unexpectedly link with lower VTE, aortic stenosis

    April 21, 2020

    Post hoc analyses of data from as many as 46,000 patients showed surprising links between PCSK9 inhibition and reduced rates of VTE and aortic stenosis.

Previous1 … 34 35 36 37 38 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences